MUC5AC, cytokeratin 20 and HER2 expression and K-RAS mutations within mucinogenic growth in congenital pulmonary airway malformations

Histopathology

Volumn 60, Issue 7, 2012, Pages 1133-1143

  Rossi, Giulio ^a   Gasser, Bernard ^b   Sartori, Giuliana ^a   Migaldi, Mario ^a   Costantini, Matteo ^c   Mengoli, Maria Cecilia ^a   Piccioli, Silvia ^a   Cavazza, Alberto ^c   Rivasi, Francesco ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Hôpitaux Universitaires de Strasbourg   (France)

^c Arcipedale St Maria Nuova   (Italy)

Author keywords

Congenital airway malformation; EGFR; HER2; KRAS; Lung; Mucin

Indexed keywords

CAUDAL TYPE HOMEOBOX 2; CYTOKERATIN 20; HOMEODOMAIN PROTEIN; MUCIN 1; MUCIN 2; MUCIN 3; MUCIN 5AC; MUCIN 6; OLIGONUCLEOTIDE; THYROID TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY LABELING; ARTICLE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONGENITAL PULMONARY AIRWAY MALFORMATION; EPIDERMAL GROWTH FACTOR RECEPTOR 2 GENE; EPIDERMAL GROWTH FACTOR RECEPTOR GENE; FEMALE; FETUS; GENE LOCATION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LUNG MALFORMATION; MALE; MUTATIONAL ANALYSIS; ONCOGENE K RAS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD;

ADENOCARCINOMA, MUCINOUS; ADOLESCENT; ADULT; BASE SEQUENCE; BRONCHOPULMONARY SEQUESTRATION; CHILD; CHILD, PRESCHOOL; DNA PRIMERS; FEMALE; FETUS; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; KERATIN-20; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUCIN 5AC; MUTATION, MISSENSE; NUCLEAR PROTEINS; RECEPTOR, ERBB-2; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84861482927     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.04170.x     Document Type: Article

References (48)

1. Ch'in KY, Tang MY. Congenital adenomatoid malformation of one lobe of a lung with general anasarca. Arch. Pathol. 1949; 48; 221-225.
2. Langston C. New concepts in the pathology of congenital lung malformations. Semin. Pediatr. Surg. 2003; 12; 17-37.
3. Stocker JT, Madewell JE, Drake RM. Congenital cystic adenomatoid malformation of the lung. Classification and morphologic spectrum. Hum. Pathol. 1977; 8; 155-171.
4. Stocker JT. Non-neoplastic lung disease. Congenital pulmonary airway malformation - Congenital pulmonary airway malformation - a new name for an expanded classification of congenital cystic adenomatoid malformation of the lung. a new name for an expanded classification of congenital cystic adenomatoid malformation of the lung. Histopathology 2002; 41(Suppl. 2); 424-431.
5. Kim WS, Lee KS, Kim IO et al. Congenital cystic adenomatoid malformation of the lung: CT-pathologic correlation. Am. J. Roentgenol. 1997; 168; 47-53.
6. Stocker JT, Husain AN. Cystic lesions of the lung in children: classification and controversies. Eur. Respir. Mon. 2007; 39; 1-20.
7. Conran RM, Stocker TJ. Extralobar sequestration with frequently associated congenital cystic adenomatoid malformation, type 2: report of 50 cases. Pediatr. Devel. Pathol. 1999; 2; 454-463.
8. Reid CJ, Gould S, Harris A. Developmental expression of mucin genes in the human respiratory tract. Am. J. Respir. Cell Mol. Biol. 1997; 17; 592-598.
9. Copin MC, Buisine MP, Devisme L et al. Normal respiratory mucosa, precursor lesions and lung carcinomas: differential expression of human mucin genes. Front. Biosci. 2001; 6; D1264-D1275.
10. Gray T, Koo JS, Nettesheim P. Regulation of mucous differentiation and mucin gene expression in the tracheobronchial epithelium. Toxicology 2001; 160; 35-46.
11. Williams OW, Sharafkhaneh A, Kim V, Dickey BF, Evans CM. Airway mucus. From production to secretion. Am. J. Respir. Cell Mol. Biol. 2006; 34; 527-536.
12. Travis WD, Brambilla E, Noguchi M et al. International association for the study of lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J. Thorac. Oncol. 2011; 6; 244-285.
13. Lantuejoul S, Nicholson AG, Sartori G et al. Mucinous cells in type 1 pulmonary congenital cystic adenomatoid malformation as mucinous bronchioloalveolar carcinoma precursors. Am. J. Surg. Pathol. 2007; 31; 961-969.
14. Stacher E, Ullmann R, Halbwedl I et al. Atypical goblet cell hyperplasia in congenital cystic adenomatoid malformation as a possible preneoplasia for pulmonary adenocarcinoma in childhood: a genetic analysis. Hum. Pathol. 2004; 35; 565-570.
15. Wang NS, Chen MF, Chen FF. The glandular component in congenital cystic adenomatoid malformation of the lung. Respirology 2002; 4; 147-153.
16. Copin MC, Buisine MP, Leteurtre E et al. Mucinous bronchioloalveolar carcinomas display a specific pattern of mucin gene expression among primary lung adenocarcinomas. Hum. Pathol. 2001; 32; 274-281.
17. Tsuchiya E, Furuta R, Wada N et al. High K-ras mutation rates in goblet-cell-type adenocarcinomas of the lungs. J. Cancer Res. Clin. Oncol. 1995; 121; 577-581.
18. Marchetti A, Buttitta F, Pellegrini S et al. Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype. J. Pathol. 1996; 179; 254-259.
19. Garfield DH, Cadranel J, West HL. Bronchioloalveolar carcinoma: the case for two diseases. Clin. Lung Cancer 2008; 9; 24-29.
20. Finberg KE, Sequist LV, Joshi VA et al. Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features. J. Mol. Diagn. 2007; 9; 320-326.
21. Sartori G, Cavazza A, Sgambato A et al. EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to EGFR inhibitors. Am. J. Clin. Pathol. 2009; 131; 478-489.
22. Rossi G, Murer B, Cavazza A et al. Primary mucinous (so-called colloid) carcinomas of the lung: a clinicopathologic and immunohistochemical study with special reference to CDX2 homeobox gene and MUC2 expression. Am. J. Surg. Pathol. 2004; 28; 442-452.
23. Wright C. Congenital malformations of the lung. Curr. Diagn. Pathol. 2006; 12; 191-201.
24. DeMello DE. Pulmonary pathology. Semin. Neonatol. 2004; 9; 311-329.
25. MacSweeney F, Papagiannopoulos K, Goldstraw P et al. An assessment of the expanded classification of congenital cystic adenomatoid malformations and their relationship to malignant transformation. Am. J. Surg. Pathol. 2003; 27; 1139-1146.
26. Hill DA, Jarzembowski JA, Priest JR, Williams G, Schoettler P, Dehner LP. Type I pleuropulmonary blastoma: pathology and biology study of 51 cases from the international pleuropulmonary blastoma registry. Am. J. Surg. Pathol. 2008; 32; 282-295.
27. Guo H, Cajaiba MM, Borys D et al. Expression of epidermal growth factor receptor, but not K-RAS mutations, is present in congenital cystic airway malformation/congenital pulmonary airway malformation. Hum. Pathol. 2007; 38; 1772-1778.
28. Ota H, Langston C, Honda T, Katsuyama T, Genta RM. Histochemical analysis of mucous cells of congenital adenomatoid malformation of the lung. Insights into the carcinogenesis of pulmonary adenocarcinoma expressing gastric mucins. Am. J. Clin. Pathol. 1998; 110; 450-455.
29. Tsuta K, Ishii G, Nitadori J et al. Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin. J. Pathol. 2006; 209; 78-87.
30. Sagawa M, Saito Y, Fujimura S, Linnoila RI. K-ras point mutation occurs in the early stage of carcinogenesis in lung cancer. Br. J. Cancer 1998; 77; 720-723.
31. Sartori G, Cavazza A, Bertolini F et al. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis. Am. J. Clin. Pathol. 2008; 129; 202-210.
32. Granata C, Gambini C, Balducci T et al. Bronchioloalveolar carcinoma arising in congenital cystic adenomatoid malformation in a child: a case report and review on malignancies originating in congenital cystic adenomatoid malformation. Pediatr. Pulmonol. 1998; 25; 62-66.
33. Lantuejoul S, Ferretti GR, Goldstraw P et al. Metastases from bronchioloalveolar carcinomas associated with long-standing type 1 congenital cystic adenomatoid malformations. Histopathology 2006; 48; 204-206.
34. West D, Nicholson AG, Colquhoun I, Pollock J. Bronchioloalveolar carcinoma in congenital cystic adenomatoid malformation of lung. Ann. Thorac. Surg. 2007; 83; 687-689.
35. Benjamin DR, Cahill JL. Bronchioloalveolar carcinoma of the lung and congenital adenomatoid malformation. Am. J. Clin. Pathol. 1991; 95; 889-892.
36. Ribet ME, Copin MC, Soots JG, Gosselin BH. Bronchioloalveolar carcinoma and congenital cystic adenomatoid malformation. Ann. Thorac. Surg. 1995; 60; 1126-1128.
37. Kaslovsky RA, Purdy S, Dangman BC et al. Bronchioloalveolar carcinoma in a child with congenital cystic adenomatoid malformation. Chest 1997; 112; 548-551.
38. Ioachimescu OC, Metha AC. From cystic pulmonary airway malformation, to bronchioloalveolar carcinoma and adenocarcinoma of the lung. Eur. Respir. J. 2005; 26; 1181-1187.
39. Mani H, Shilo K, Galvin JR, Stocker TJ, Franks TJ. Spectrum of precursor and invasive neoplastic lesions in type 1 congenital pulmonary airway malformation: case report and review of the literature. Histopathology 2007; 51; 552-580.
40. Khan NU, Jones MT, Greaves M. Congenital cystic adenomatoid malformation of an entire lung in a 33-year-old man: a case report and review of the literature. Br. J. Radiol. 2008; 81; e276-e278.
41. Summers RJ, Shehata BM, Bleacher JC, Stockwell C, Rapkin L. Mucinous adenocarcinoma of the lung in association with congenital pulmonary airway malformation. J. Pediatr. Surg. 2010; 45; 2256-2259.
42. Fitzgerald DA. Congenital cyst adenomatoid malformations: resect some and observe all? Paediatr. Respir. Rev. 2007; 8; 67-76.
43. Lo AYS, Jones S. Lack of consensus among Canadian pediatric surgeons regarding the management of congenital cystic adenomatoid malformation of the lung. J. Pediatr. Surg. 2008; 43; 797-799.
44. Kim HK, Choi YS, Kim K et al. Treatment of congenital cystic adenomatoid malformation: should lobectomy always be performed? Ann. Thorac. Surg. 2008; 86; 249-253.
45. Franklin WA, Gumerlock PH, Crowley J et al. EGFR, HER2 and ERB-B pathway activation in bronchioloalveolar carcinoma (BAC): analysis of SWOG 9417 and lung SPORE tissue samples. Proc. Am. Soc. Clin. Oncol. 2003; 22; 620.
46. Casali C, Rossi G, Marchioni A et al. A single institution-based retrospective study of surgically treated bronchioloalveolar adenocarcinoma of the lung. Clinicopathologic analysis, molecular features, and possible pitfalls in routine practice. J. Thorac. Oncol. 2010; 5; 830-836.
47. Basbaum C, Lemjabbar H, Longphre M, Li D, Gensch E, McNamara N. Control of mucin transcription by diverse injury-induced signaling pathways. Am. J. Respir. Crit. Care Med. 1999; 160; S44-S48.
48. Burgel PR, Nadel JA. Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium. Thorax 2004; 59; 992-996.